Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A53584 | Pages: 434 | Charts: 70 | Tables: 135 |
The global c-arms market size was valued at $2,003.12 million in 2021, and is projected to reach $3,233.76 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031. C-Arm is a medical imaging device that is based on X-ray technology and can be used flexibly in various operation rooms within a clinic. The name is derived from the C-shaped arm used to connect the X-ray source and X-ray detector to one another. C-Arms comprises a generator called X-Ray source and an image intensifier for a flat panel detector. It is often used in surgery, orthopedics, traumatology, vascular surgery, and cardiology for intra-operative imaging. The device provides high-resolution X-ray images in real time, allowing the surgeon to monitor progress at any point during the surgery.
[COVIDIMPACTSTATEMENT]
Market dynamics
The increase in the prevalence of chronic disease due to changing lifestyles such as heart diseases, diabetes, cardiovascular disease, chronic respiratory diseases, and others cause mortality and morbidity across the world, rising number of surgical procedures, and an increasing demand for technologically advanced medical devices are the major factors driving the growth of the C-arms market share. For instance, according to the report published by World Health Organization in September 2022, noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. Each year, 17 million people die from NCD before age 70; 86% of these premature deaths occur in low- and middle-income countries of all NCD deaths, 77% are in low- and middle-income countries. In addition, cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes). Moreover, the rise in technological advancements in C-arms, such as improved imaging resolution and image intensifier tubes, are expected to fuel the C-arms market growth. These advancements have enabled C-arms to be used for a variety of purposes, including vascular surgeries, orthopedic surgeries, and tumor treatment. For instance, in June 2022, Siemens AG, launched its new, ceiling-mounted Artis icono ceiling angiography system. It provides three-dimensional (3D) data both at the patient’s head and from the patient’s side over a complete angular range of 200 degrees. The demand for C-arms devices is not only limited to developed countries, but is also being witnessed in developing countries, owing to the rapid increase in geriatric populations of countries such as China, Brazil, and India, which fuel the growth of the market.
However, the high cost of C-arms devices and lack of skilled professional hampers the C-arms market size. As it can limit the number of potential buyers and restrict the ability of hospitals and diagnostic clinics to acquire the latest technology. This can lead to a decrease in the adoption of technologically advanced diagnostic devices in clinics and hospitals, resulting in a decrease in the quality of X-ray images. Emerging economies such as India, China, Mexico, and Brazil, are anticipated to create new opportunities during the forecast period owing to the rise in geriatric population and increase in interest in minimally invasive surgeries as there are minimal stitches on the body and rapid increase in the number of chronic diseases.
Segmental Overview
The C-arms market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into mobile C-arms and fixed C-arms. The mobile C-arms is further segmented into a mini-C-arms and full-size C-arms. By application it is bifurcated into cardiology, gastroenterology, neurology, orthopedic & trauma, oncology, and others. By end user, it is segmented into hospitals, diagnostic centers, and specialty clinics. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By type
The market is segmented into mobile C-arms and fixed C-arms. The mobile C-arms segment accounted for the largest share of the market. The dominance of this segment can be attributed to the ability of mobile C-arms to move around the patient, achieving the best angle for a high-quality image while keeping the patient comfortable, is one of its most significant advantages.
[TYPEGRAPH]
By application
The market is segmented into cardiology, gastroenterology, neurology, orthopedic & trauma, oncology, and others. The orthopedic & trauma segment accounted for the largest share of the market. The dominance of this segment can be attributed to the high incidence of musculoskeletal disease, increase in the number of road accidents and sports-related injuries, and a rise in the geriatric population.
[APPLICATIONGRAPH]
By end user
The market is segmented into hospitals, diagnostic centers, and specialty clinics. The hospitals segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period, owing to the fact that hospitals are the primary end-users of C-arms devices, and are the main source of revenue for C-arms device vendors. The demand for C-arms devices in hospitals is driven by the need for mobile imaging, which is used for a variety of medical procedures, including orthopedic, vascular, and gastrointestinal surgeries.
[ENDUSERGRAPH]
By region
The C-arms market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the C-arms market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major key players and the rising advancement in technology in this region drive the growth of the market. Moreover, increase in the prevalence of chronic disease, the rapid increase in the geriatric population, rising demand for minimally invasive surgical procedures, increasing adoption of technologically advanced C-arms devices and improved healthcare infrastructure, are the major factor driving the growth of the C-arms market in this region.
Asia-Pacific is expected to grow at the highest rate during the C-arms market forecast. The market growth in the Asia-Pacific region is supplemented by highly populated countries along with increasing collaboration between key organizations and hospitals to improve quality of healthcare and research infrastructure, availability of government funding for research activities, and growing application of C-arms devices for the diagnosis of disease and provide better image quality.
[REGIONGRAPH]
COMPETITION ANALYSIS
The report provides competitive analysis and profiles of the major players in the C-arms market, such as Canon Inc, Fujifilm Holding Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V., Nanjing Perlove Medical Equipment Co. Ltd., Shimadzu Corporation, Siemens AG, Trivitron Healthcare and Ziehm Imaging GmbH.
Some examples of product launches are
In June 2022, Siemens AG, launched its new, ceiling-mounted Artis icono ceiling angiography system. It provides three-dimensional (3D) data acquisitions both at the patient’s head and from the patient’s side over a complete angular range of 200 degrees. Thus, launch of the new C-arms device Artis icono will help the company to gain a strong foothold in the C-arms industry.
In February 2022, Siemens AG, launched Artis icono biplane to expand its cardiology portfolio. It offers new features for diagnosing and treating cardiac arrhythmia, coronary heart disease, and structural heart disease that simplify clinical workflows and provides excellent image quality at a low radiation dose.
In January 2022, Philips announced the launch of advanced new 3D image guidance capabilities device through its image-guided therapy mobile C-arms System – Zenition. It delivers enhanced clinical accuracy, efficiency, and aims to improve the outcomes for patients undergoing endovascular treatment.
In November 2021, FUJIFILM Healthcare launched the Persona CS mobile fluoroscopy system, its new, compact mobile C-arms imaging solution designed for rapid and seamless positioning in operating room (OR) environments.
In March 2021 GE Healthcare, announced 510(k) clearance from the U.S. FDA for OEC 3D, a new surgical imaging system capable of 3D and 2D imaging. This product will set a standard for interoperative 3D imaging with precise volumetric images for spine and orthopedic procedures. This new system combines the benefits and familiarity of 2D imaging with greater efficiency to increase access and usability to 3D.
Key Market Segments
Key Market Players